Toxic epidermal necrolysis involving extensive body surface area: a case report and review

Autores/as

  • Claudio José dos Santos Júnior Universidade de São Paulo, Faculdade de Saúde Pública, São Paulo, (SP), Brasil https://orcid.org/0000-0002-2853-1968
  • Paulo Victor Muniz Azevedo Centro Universitário CESMAC, Maceió, (AL), Brasil
  • Aryanna Kelly Pinheiro Souza Universidade Federal de Alagoas, Maceió, (AL), Brasil https://orcid.org/0000-0003-1235-9144
  • Thiago José Matos Rocha Universidade Estadual de Ciências da Saúde de Alagoas, Maceió, (AL), Brasil https://orcid.org/0000-0001-5153-6583

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2026.213252

Palabras clave:

Stevens-Johnson Syndrome, Drug-related side and adverse reactions, Drug eruptions, Phenytoin

Resumen

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are a set of illnesses caused by a mucocutaneous hypersensitivity reaction, with an acute character and significant potential to threaten life. In this study, we report a case of severe cutaneous and mucosal reaction, of the TEN type involving 95% of the body surface after the use of phenytoin. The patient scored 4 points on the SCORTEN score, having presented ocular and oral mucosa involvement, in addition to secondary infection by multidrug-resistant Acinetobacter baumannii. Therapy included broad-spectrum antimicrobial coverage, in addition to isolation in an intensive care unit with a negative pressure system, corticosteroid therapy and support measures, such as eye lubrication, lip hydration and environmental temperature control. The patient was discharged after 30 days of hospitalization, having evolved with clinical and laboratory improvement, with complete regression of the injuries that motivated the admission. She is currently undergoing outpatient follow-up at a dermatology service, with no record of relevant complications.

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

  • Claudio José dos Santos Júnior, Universidade de São Paulo, Faculdade de Saúde Pública, São Paulo, (SP), Brasil

    PhD 

  • Paulo Victor Muniz Azevedo, Centro Universitário CESMAC, Maceió, (AL), Brasil

    Medical student 

  • Aryanna Kelly Pinheiro Souza, Universidade Federal de Alagoas, Maceió, (AL), Brasil

    Bachelor's degree 

  • Thiago José Matos Rocha, Universidade Estadual de Ciências da Saúde de Alagoas, Maceió, (AL), Brasil

    PhD 

Referencias

1. Bakshi SS. Stevens-Johnson syndrome. Intern Emerg Med. 2018 Nov;14(2):323-4.

2. Ergen EN, Hughey LC. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. JAMA Dermatol. 2017 Dec;153(12):1344.

3. Ojo DE, Tiab F, Walden D, Bernacki S, Bagley M. A Peculiar Case of Idiopathic Herpes-Zoster-Like Stevens-Johnson Syndrome (SJS). Cureus. 2023 Mar;15(3):e36190.

4. Noe MH, Micheletti RG. Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Clin Dermatol. 2020 Jun.

5. Oakley AM, Krishnamurthy K. Stevens-Johnson Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. PMID: 29083827.

6. Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clin Rev Allergy Immunol. 2017 Nov;54(1):147-76.

7. Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017 Oct;390(10106):1996-2011.

8. Chang WC, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Beachkofsky TM, et al. SJS/TEN 2019: From science to translation. J Dermatol Sci. 2020 Apr;98(1):2-12.

9. Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, et al. Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. JAMA Dermatol. 2017 Jun 1;153(6):514.

10. Grünwald P, Mockenhaupt M, Panzer R, Emmert S. Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment. JDDG: J Dtsch Dermatol Ges. 2020 May;18(6):547-53.

11. Charlton OA, Harris V, Phan K, Mewton E, Jackson C, Cooper A. Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review. Adv Wound Care (New Rochelle). 2020 Jul;9(7):426-39.

12. Schneider JA, Cohen PR. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Adv Ther. 2017;34(6):1235-44.

13. Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. Medicina. 2021 Aug 28;57(9):895.

14. Shah R, Chen ST, Kroshinsky D. Use of Cyclosporine for the treatment of Steven Johnson Syndrome/Toxic Epidermal Necrolysis. J Am Acad Dermatol. 2019 Jan.

15. Torres-Navarro I, Briz-Redón Á, Botella-Estrada R. Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):159-71.

16. Ueta M. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications. Expert Rev Clin Immunol. 2020 Mar;16(3):285-91.

17. Kinoshita Y, Saeki H. A review of toxic epidermal necrolysis management in Japan. Allergol Int. 2017 Jan;66(1):36-41.

18. Harr T, French LE. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Chem Immunol Allergy. 2012;149–66.

19. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: A Severity-Of-Illness Score for Toxic Epidermal Necrolysis. J Invest Dermatol. 2000;115(2):149-53.

20. Majumdar S, Mockenhaupt M, Roujeau JC, Townshend AP. Interventions for toxic epidermal necrolysis. Cochrane Database Syst Rev. 2002 Oct 21.

Descargas

Publicado

2026-11-18

Número

Sección

Relato de Caso

Cómo citar

1.
Santos Júnior CJ dos, Azevedo PVM, Souza AKP, Rocha TJM. Toxic epidermal necrolysis involving extensive body surface area: a case report and review. Medicina (Ribeirão Preto) [Internet]. 18 de noviembre de 2026 [citado 18 de noviembre de 2026];59(1):e-213252. Disponible en: https://revistas.usp.br/rmrp/article/view/213252